Osawa Y, Davila J C
Laboratory of Chemical Pharmacology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.
Biochem Biophys Res Commun. 1993 Aug 16;194(3):1435-9. doi: 10.1006/bbrc.1993.1985.
Phencyclidine, 1-(1-phenylcyclohexyl)piperidine, was shown in this study to be an effective irreversible inhibitor of brain nitric oxide synthase, the enzyme responsible for the conversion of L-arginine to nitric oxide. The inactivation of nitric oxide synthase was time- and concentration-dependent and required reduced nicotinamide adenine dinucleotide phosphate, a necessary cofactor for nitric oxide synthesis. These results indicate that phencyclidine is metabolized by nitric oxide synthase to reactive intermediates that irreversibly inactivate the enzyme. The inactivation of nitric oxide synthase by xenobiotics, such as phencyclidine, may be pharmacologically and toxicologically important due to the role of nitric oxide in a variety of physiological processes.
本研究表明,苯环利定(1-(1-苯基环己基)哌啶)是脑一氧化氮合酶的一种有效不可逆抑制剂,该酶负责将L-精氨酸转化为一氧化氮。一氧化氮合酶的失活具有时间和浓度依赖性,并且需要还原型烟酰胺腺嘌呤二核苷酸磷酸,这是一氧化氮合成所必需的辅助因子。这些结果表明,苯环利定被一氧化氮合酶代谢为活性中间体,从而不可逆地使该酶失活。由于一氧化氮在多种生理过程中的作用,外源性物质(如苯环利定)对一氧化氮合酶的失活在药理学和毒理学上可能具有重要意义。